ethyl 3-amino-1h-pyrazole-4-carboxylate has been researched along with cyclic nucleotide phosphodiesterases, type 4 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artis, DR; Blasdel, L; Bollag, G; Card, GL; England, BP; Fong, D; Gillette, S; Ibrahim, PN; Kim, SH; Milburn, MV; Schlessinger, J; Suzuki, Y; Zhang, C; Zhang, KY | 1 |
1 other study(ies) available for ethyl 3-amino-1h-pyrazole-4-carboxylate and cyclic nucleotide phosphodiesterases, type 4
| Article | Year |
|---|---|
A family of phosphodiesterase inhibitors discovered by cocrystallography and scaffold-based drug design.
Topics: Binding Sites; Crystallography; Drug Delivery Systems; Drug Design; Peptide Fragments; Peptide Library; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Protein Binding; Protein Interaction Mapping | 2005 |